Tandem Diabetes Care IncTNDM
Price$16.50

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $1B+10.8% YoYTTM through 30 Jun 2026
Net Income -$63.3MTTM through 30 Jun 2026
Free Cash Flow -$26.6MTTM through 30 Jun 2026

Margins

Current
Gross Margin55.0%
EBITDA Margin-2.7%
Operating Margin-7.0%
Net Margin-6.1%

Returns

-48.6%ROE
-5.5%ROA

Balance Sheet Health

Debt / Equity4.55x
Current Ratio3.58x
Net Debt$31.5M
Cash & Equivalents$62.8M

Quality Metrics

Altman Z-Score0.49
Piotroski F-Score4 / 9
FCF Margin-2.6%
Rule of 400.4
Earnings-Beat Rate75.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $1B
Diluted EPS-$0.93TTM
'19'20'21'22'23'24'25
FY2025: $-3.04

Dividend

No dividend

Capital Allocation

Capex Intensity2.0%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.